Search Media Items

The Lung Cancer Master Protocol, or Lung-MAP, is a precision medicine research study for people with advanced non-small cell lung cancer that has continued to grow after treatment. Patients are assigned to different study drug combinations based on the results of genomic profiling of their tumors.

The NCI Outstanding Investigator Award (OIA) supports investigators with outstanding records of productivity in cancer research by providing extended funding stability and encouraging investigators to continue or embark on projects of unusual potential in cancer research.

Cancer drug discovery and development has long been a priority for the National Cancer Institute, most importantly in areas of need that are not being adequately addressed by the private sector.

Resumen de información revisada por expertos acerca del tratamiento de los tumores vasculares infantiles.

Resumen de información revisada por expertos sobre los antineoplastones como tratamiento para personas con cáncer.

Resumen de información revisada por expertos sobre los antineoplastones como tratamiento para personas con cáncer.

Resumen de información revisada por expertos sobre el uso del laetrilo (amigdalina) como tratamiento para personas con cáncer.

People with cancer may face major financial challenges and need help dealing with the high costs of care. Cancer treatment can be very expensive, even when you have insurance. Learn ways to manage medical information, paperwork, bills, and other records.

Highlighting key topics in cancer surveillance, this video from the National Cancer Institute (NCI) looks at Human Papillomavirus trends in the United States. Here is NCI's information on HPV: http://www.cancer.gov/hpv-factsheet Find more cancer statistics from NCI's Surveillance, Epidemiology, and End Results (SEER) Program: http://www.seer.cancer.gov

This RAS Biochemistry and Biophysics lab investigates signaling by RAS proteins, which is regulated by the interactions with substrates, protein partners, and membranes.